Cargando…

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Detalles Bibliográficos
Autores principales: Işık, Ayşe, Eliaçık, Eylem, Haznedaroğlu, İbrahim C., Aksu, Salih, Sayınalp, Nilgün, Büyükaşık, Yahya, Göker, Hakan, Özcebe, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878545/
https://www.ncbi.nlm.nih.gov/pubmed/24385816
http://dx.doi.org/10.4274/Tjh-2013.0005
_version_ 1782297826191998976
author Işık, Ayşe
Eliaçık, Eylem
Haznedaroğlu, İbrahim C.
Aksu, Salih
Sayınalp, Nilgün
Büyükaşık, Yahya
Göker, Hakan
Özcebe, Osman
author_facet Işık, Ayşe
Eliaçık, Eylem
Haznedaroğlu, İbrahim C.
Aksu, Salih
Sayınalp, Nilgün
Büyükaşık, Yahya
Göker, Hakan
Özcebe, Osman
author_sort Işık, Ayşe
collection PubMed
description
format Online
Article
Text
id pubmed-3878545
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-38785452014-01-02 The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia Işık, Ayşe Eliaçık, Eylem Haznedaroğlu, İbrahim C. Aksu, Salih Sayınalp, Nilgün Büyükaşık, Yahya Göker, Hakan Özcebe, Osman Turk J Haematol Letter to Editor Galenos Publishing 2013-09 2013-09-05 /pmc/articles/PMC3878545/ /pubmed/24385816 http://dx.doi.org/10.4274/Tjh-2013.0005 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Işık, Ayşe
Eliaçık, Eylem
Haznedaroğlu, İbrahim C.
Aksu, Salih
Sayınalp, Nilgün
Büyükaşık, Yahya
Göker, Hakan
Özcebe, Osman
The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title_full The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title_fullStr The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title_full_unstemmed The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title_short The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
title_sort impact of eltrombopag administration on the clinical course of severe refractory fatal acquired aplastic anemia
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878545/
https://www.ncbi.nlm.nih.gov/pubmed/24385816
http://dx.doi.org/10.4274/Tjh-2013.0005
work_keys_str_mv AT isıkayse theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT eliacıkeylem theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT haznedarogluibrahimc theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT aksusalih theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT sayınalpnilgun theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT buyukasıkyahya theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT gokerhakan theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT ozcebeosman theimpactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT isıkayse impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT eliacıkeylem impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT haznedarogluibrahimc impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT aksusalih impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT sayınalpnilgun impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT buyukasıkyahya impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT gokerhakan impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia
AT ozcebeosman impactofeltrombopagadministrationontheclinicalcourseofsevererefractoryfatalacquiredaplasticanemia